NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









inflamed pharma

inflamed pharma

Private
JenaHealthcare & Life Scienceshttps://inflamedpharma.com/

Last Round

Grant

Mar 23, 2020

Company Overview

inflamed pharma is a biotechnology company that provides a patented technology platform, JenCluTec®, to increase the water solubility and membrane permeability of small molecules.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical Imaging

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

solubility enhancementdrug formulationdrug delivery technologybioavailability enhancementAPI solubilitysmall molecule formulationdrug rescueCDMO servicespharma servicesactive pharmaceutical ingredientAPItherapeutic developmentGMP manufacturingdiagnostic developmentPET tracer

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

inflamed pharma Comparables

Compare inflamed pharma with similar companies based on industry and business-model similarity.

inflamed pharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Zerion Pharma
86%
Harpago
82%
AustinPx
79%

inflamed pharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 23, 2020

inflamed pharma Investors

Notable investors and investment history

inflamed pharma investors
InvestorRounds
European Regional Development FundGrant
Xlife Sciences AGSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 23, 2020

    Received grant funding from the European Regional Development Fund.

inflamed pharma Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

inflamed pharma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about inflamed pharma's valuation, stock price, and market status.

Firmographic Details

HeadquartersJena
Year Founded2016
Last FundingMar 23, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.